Linscomb & Williams Inc. Buys 241 Shares of Waters Co. (NYSE:WAT)

Linscomb & Williams Inc. grew its stake in shares of Waters Co. (NYSE:WAT) by 3.7% in the first quarter, HoldingsChannel.com reports. The firm owned 6,721 shares of the medical instruments supplier’s stock after purchasing an additional 241 shares during the period. Linscomb & Williams Inc.’s holdings in Waters were worth $1,910,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of WAT. First Trust Advisors LP bought a new stake in Waters during the 1st quarter worth approximately $1,744,000. Creative Planning boosted its stake in shares of Waters by 14.3% in the 4th quarter. Creative Planning now owns 1,635 shares of the medical instruments supplier’s stock worth $405,000 after buying an additional 205 shares during the last quarter. California Public Employees Retirement System boosted its stake in shares of Waters by 4.8% in the 4th quarter. California Public Employees Retirement System now owns 146,301 shares of the medical instruments supplier’s stock worth $36,198,000 after buying an additional 6,700 shares during the last quarter. Treasurer of the State of North Carolina boosted its stake in shares of Waters by 0.3% in the 4th quarter. Treasurer of the State of North Carolina now owns 23,465 shares of the medical instruments supplier’s stock worth $5,806,000 after buying an additional 80 shares during the last quarter. Finally, Savant Capital LLC boosted its stake in shares of Waters by 3.8% in the 4th quarter. Savant Capital LLC now owns 1,239 shares of the medical instruments supplier’s stock worth $307,000 after buying an additional 45 shares during the last quarter. 87.37% of the stock is owned by hedge funds and other institutional investors.

A number of brokerages have recently weighed in on WAT. Wells Fargo & Company boosted their target price on Waters from $280.00 to $290.00 and gave the stock an “underweight” rating in a research note on Thursday, May 6th. SVB Leerink boosted their target price on Waters from $290.00 to $300.00 and gave the stock a “market perform” rating in a research note on Thursday, May 6th. Three equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and one has given a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus price target of $249.56.

In other news, Director Michael J. Berendt sold 1,161 shares of the company’s stock in a transaction on Monday, May 24th. The shares were sold at an average price of $318.24, for a total value of $369,476.64. Following the transaction, the director now owns 21,255 shares of the company’s stock, valued at $6,764,191.20. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Linda Baddour sold 1,249 shares of the company’s stock in a transaction on Thursday, May 13th. The stock was sold at an average price of $314.99, for a total transaction of $393,422.51. Following the completion of the transaction, the director now directly owns 3,046 shares in the company, valued at approximately $959,459.54. The disclosure for this sale can be found here. Insiders own 1.10% of the company’s stock.

Waters stock opened at $333.77 on Friday. Waters Co. has a 12 month low of $171.38 and a 12 month high of $334.49. The company has a current ratio of 2.25, a quick ratio of 1.83 and a debt-to-equity ratio of 6.94. The firm has a 50 day moving average price of $309.27. The stock has a market capitalization of $20.59 billion, a P/E ratio of 33.82, a price-to-earnings-growth ratio of 4.47 and a beta of 0.81.

Waters (NYSE:WAT) last issued its earnings results on Wednesday, May 5th. The medical instruments supplier reported $2.29 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.57 by $0.72. Waters had a net margin of 24.56% and a return on equity of 1,107.70%. The business had revenue of $608.55 million for the quarter, compared to analysts’ expectations of $522.81 million. During the same quarter in the previous year, the firm posted $1.15 EPS. The business’s revenue for the quarter was up 30.9% compared to the same quarter last year. Equities analysts anticipate that Waters Co. will post 10.01 earnings per share for the current year.

Waters Profile

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Featured Story: What is the NASDAQ?

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.